IARC estimates 34,279 new cancer cases and 19,963 cancer deaths in Iraq in 2024; the commonest new cancers are breast, trachea, bronchus and lung and leukaemia. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 7,461 | 42.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 2,758 | 10.8 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Leukaemia | 2,252 | 6.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Colorectum | 2,155 | 7.3 | Colorectal cancer |
| Bladder | 1,776 | 6.9 | Bladder & urothelial cancer |
| Non-Hodgkin lymphoma | 1,613 | 4.9 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Brain, central nervous system | 1,588 | 4.5 | Glioma & glioblastoma |
| Thyroid | 1,426 | 3.7 | Thyroid cancer |
| Stomach | 1,090 | 3.8 | Gastric & gastro-oesophageal junction cancer |
| Prostate | 927 | 9.5 | Prostate cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 3,366 | 19.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 2,621 | 10.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Leukaemia | 1,472 | 4.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Brain, central nervous system | 1,278 | 3.8 | Glioma & glioblastoma |
| Colorectum | 1,223 | 4.3 | Colorectal cancer |
| Bladder | 1,073 | 4.3 | Bladder & urothelial cancer |
| Stomach | 853 | 3.1 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 786 | 3.0 | Pancreatic ductal adenocarcinoma |
| Non-Hodgkin lymphoma | 732 | 2.4 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Liver and intrahepatic bile ducts | 682 | 2.6 | Hepatocellular carcinoma |
No trial record in OnCo lists a site in Iraq. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Iraq.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Iraq is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Iraq is ranked 23 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.